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The lissuc inhibitors of mclalloprotuinascs TIMP- I and TIMP-2 were purilied to itpparcni homogcncity from human rheumatoid synovial fluid 
(HRSF). The inhibitors were isolaled by dissocialion of non-covalen1 gclaiinaseiTIMP con~plcxes. TIMP-I migrnlcd as a single polypcplidc wilh 
M, 23 500 on SDS-PAGE, while the M, of TIMP-2 was 21 000. The inhibitory aclivily was stable under heat and acid pH. N-lcrminal sequence 
data were oblained for the first IS residues of both inhibitors and showed identhy to the human libroblast inhibitors TlMP-I and TIMP-2. This 
is the first demonsh-ation that TIMP-I and TI1VIP-2 can be directly purified from human rheumatoid synovial fluid. The complex formation between 
lhe melalloproleinase inhibitors and lcucocyte mcialloproteinascs was shown by immunobloliing. 
Tissue inhibitor of mc~alloproleinase: Gclatinase; Rheumatoid synovial Ruid 
1, 1NTRODUCTlON 2. MATERlALS AND METI-IODS 
The tissue inhibitor of mctalloproteinases, TIMP-1, 
is a glycoprotein with an apparent molecular mass of 
28 500 and was isolated from difl’erent tissues and body 
fluids [l--4]. TIMP-2 is a non-glycosylated protein with 
a molecular mass of 21 000, in most cases isolated as a 
complex with the proenzyme of gelatinase, i.e latent M, 
72 000 gelatinase from different culture media [5-71. 
Both inhibitors specifically inhibit the matrix metallo- 
proteinases, collagenase, gelatinase, stromelysin and 
PUMP- 1, which degrade extracellular matrix compo- 
nents such as collagens, proteoglycan, fibronectin and 
others. It has been found that TIMP- 1 forms a complex 
with latent Ad, 92 000 gelatinase, while TIMP-2 is able 
to form a complex with M, 72 000 gelatinase. All TIMP 
complexes can be activated e.g. by APMA and then 
generate gelatinolytic activity, which can be inhibited by 
the addition of more TIMP-1 or TIMP-2 [6,8,9]. These 
results indicate that regulation of the extracellular ma- 
trix degradation is more complex than assumed before 
and that both inhibitors TIMP-1 and TIMP-2 play im- 
portant roles in controlling matrix metalloproteinase 
activity in vivo. A decrease in TIMP-1 and TIMP-2 
levels can be expected to initiate uncontrolled egrada- 
tion of the extracellular matrix as observed in patholo- 
gical conditions, such as rheumatoid arthritis. 
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GO0 ml rheumatoid synovial fluid was dialyzed against 50 mM 
Tris-HCI pH 7.5. I mM CaC12, 300 mM NaCl and 0.02% NaN, (buffel 
A). The sample was supplemented with hyaluronidasc und stirred 
overnight a~ 20°C. This solution was cenirifuged for 20 min a~ 48 000 
x g LO rcmovc insoluble material and was ihen applied to an anion- 
exchange column (DEAE-ASO; 3.2 x IO cm) equilibrated with buffel 
A. The break-through fractions containing the gclatinasc/TIMPcom- 
plexes free ofhyaluronic acids were adjusted IO 0.5 M NaCl and stirred 
with 30 ml gelaiin Sepharosc for 1 h al 4°C. The IoJdcd gelatin 
sepharose wuswushcd with 50 mM Tris-HCI pl-I 7.5, I mM CaCI,. 500 
mM NaCI, 0.02% NaN, (buffer 13) and filled into a column (1.6 x 30 
cm), The gelatinasc/TlMP complcxus were eluled by adding 500 mM 
N&l and 2.5% (v/v) Me,SO to buffer B. The cluatc was concentrated 
by ultraiilma~ion using an Amicon PM IO membrane. The dissocialion 
of lhc gclatinascfllMP complexes was performed by gilliltraiion 
chromatography using Ultrogcl AcA 44 (2.6 x 77 cm) in 20 mM 
Tris-I-ICI pH 7.5. 50 mM NKI. 0. I4 NaDodSO, (buffer C). The 
inhibitor conlaining fractions wcrc dialyzed agains 20 m&l Tris-HCI 
pH 5.5, 1 mM CaCI?. IO mM NaC1,0.005% (w/v) Triton X-100,0.02% 
NaN, (buffer D). 
This solution was subjected LO a Q-Scpharosc fast-flow column (1.6 
x 3 cm). TIMP-I was retarded by this column, while adsorbed TIMP-2 
could be cluied with a linear gradient of0.01 to 0.2 M NaCl (80 ml). 
TlMP-1 or TIMP-2 fractions wcrc concentrated by ulrraliltration 
using an Amicon PM5 membrane, dialyzed against 20 mM Tris-HCI 
pH 7.5, I mM CaCI,. 0.005% Tritan X-100.0.02% NaN, and used for 
further characlerization. 
2.2. SDS-PAGE 
SDS-PAGE was performed according to the method of Lnemmli 
[IO], Proteins were stained with silver as described by Heukeshoeven 
and Dernick [I I]. 
Amino-terminal sequence determinations were performed as reccm- 
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ly published [I?] using a microsequencer (Model 810, Knauer, Berlin, 
Germany). 
Purified TIMP-I or TIMP-1 was blotted l’rom unstained SDS- 
PAGE on10 PVDF membranes by using the l3iometru fast blot system. 
The membrane wos’incubuted for 30 min with 3% DSA (w/v) in 
TBST-buTTcr (50 mM Tris-HCI pH 7.9, 150 mM NaCI, 0.05% Twecn 
20). for IO min in TBST-buffer and 90 min with 50 ,ug latent OI 
activated matrix mctalloprotcinasc (PMNL collngcnasc or gclntinttsc) 
in TBST-buffer. The control rcmaincd in TDST-buffer. Mcmbruncs 
were washed with TBST-bufrcr for 5 min. inhibitor/matrix mctallo- 
protcinasc complexes were incubated with rabbit polyclonal antibod- 
ies specilic for PMNL-gelatinnsc or collagcnascc. After 90 min reaction 
time the blots were washed with TBST-bulTcr for 10 min. The antigen! 
antibody complexes were dctccted using anti-rabbit alkaline phos- 
phnlasc conjugdtcd second antibodies as rcccnlly published [131. 
XI. ASSII,V of tttclullu(~rorrittu.s~ itrhihiror activity 
Inhibitory wivity was detcrmincd measuring the clcavugc of the 
synthetic octupcptide (dinitrophcnyl-Pro-Ciln-Gly-lie-Ala-Gly-Ciln- 
D-Arg-OH) [I41 by active PMNL gclutinasc or collagenasc in the 
prcscnce or abscncc or mctalloproteinase inhibilor. 
1.7. Purijicrtriott C$ PMNL gchrittuw UJU/ CO~~~L’IIUSL’ 
PMNL gclatinase and collagcnasc were purified according to the 
methods dcscribcd in [IS, I cl]. 
2.8. Clturocrcri:ctriott of rrhhir pdyclutrol mtri-PMNL gnlutittctse clrtd 
C~O~I~CWW ottriscrrt 
The specificity of the antibodies was recently published in [ 131. 
1.9. Pwpurutiott ctttd rhoracreri:utiott oJ rubhit poi_sclortul TIMP-I 
otfriscru 
The method t-or purilication and charactcriration was recently dc- 
scribed [I 31. 
2. IO. Drtecriorr of TIMP-f by itrrtttrrttohIottirt~ 
This was carried out as for the dctcction or matrix mclul!opio- 
tcina&iIMP complcxcs. but without incubation with enzyme solu- 
tions. 
3. RESULTS AND DISCUSSlON 
The metalloproteinase inhibitors TIMP-1 and TIMP- 
2 were purified to homogeneity from human rheuma- 
toid synovial fluid by a series of chromatographic steps 
(Table 1). Purification could be carried out, as TIMP’ 
complexes of latent and active gelatinase were bound to 
gelatin sepharose column, aIlowing easy separation of 
the complexes from most contaminating proteins. The 
isolated geIatinasc/TiMP complexes were dissociated 
by gelfiltration in the presence of 0.1% SDS (Fig. I). 
This demonstrates that gelatinase/TTlMP complexes 
exist in a non-covalent form. In contrast to other re- 
ports [6,7] the isolated gelatinase was active, which 
could bc due to using human rheumatoid synovial fluid 
or activation by SDS. The separation of TIMP-I from 
TIMP-2 was achieved by chromatography on Q-Sepha- 
rose fast-flow. While TIMP-I was not or only weakly 
bound to this column, TIMP-2 was eluted between 0.08 
and 0.15 M NaCI. Further contaminating protein eluted 
with 0.5 M NaCi or I .O M NaCl (Fig. 2). This chromat- 
ographic procedure yielded pure TIMP-1 ahd TIMP-2 
free of any other proteins. This is documented by SDS- 
PAGE (Fig. 3) showing a single protein band for each 
inhibitor with a molecular mass of 28 SOD (TIMP-I) or 
21 000 (TIMP-2). N-terminal sequence determination 
I I I 1 I 1 1 1 
10 20 39 40 60 fS-9 70 90 90 100 1 
Fraction Number 
Fig. I. GclatinascITIMP complex dissociation by SDS-gclfiltration on Ultrogcl AcA 44 column. Conccntratcd fractions rrom gclatinsepharose (1 
ml) were applied to an Ultrogcl AcA 44 column (2.6 x 77 cm) equilibrated with huller C. Fractions (I .S ml) wcr$ collcctcd al a Ilow rate of 10 
ml/h and ilntilyzcd for protein by silver stained SDS-PAGE. Gclatinasc (- - - - -) or inhibitor (--) containing fractions were combincd and dialyzed 
against buffer D, 
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Fig. 2. Separation ol’TIM P- I from TI MP-2 by Q-Scpharosc. Dialyzed 
inhibitor conwining lkictions WCK tipplicd lo P Q-Scphi~rose column 
(I .6 x 3 cm) cquilibrakd with bulk D. Fractions (2 ml) were collected 
at a Row rate of 30 ml/h. Bound protein was cluted using a linetir 
grndient (0.01-0.2 M NuCI) ;Ind analyzed for TIMP-1 and TIMP-2 
by silver stained SDS-PAGE and inhibitor assay. TIMP-I (- - - -) OI 
TIMP.2 (-_) containing frxtions were combined and used for further 
charactcrieation, 
revealed total identity of the isolated rheumatoid syno- 
vial fluid inhibitor TlMP-1 with human fibroblast in- 
hibitor TIMP-1 in the first 15 residues (Table 2). Fur- 
thermore, the first 15 amino acid residues of the &!I, 
21 000 inhibitor shared total homology with TIMP-2 
isolated from human melanoma cells [7] or recombinant 
TIMP-2 [I 71. Both inhibitors were stable up to pH2 and 
temperatures up to 100°C for 30 min, and were iaacti- 
30.0 - 
20.1 - 
14.4 - 
Fig. 3. Isolated human rheumatoid synovial tluid inhibitors and im- 
munological dctcction by TIMP-I antibodies. Lnnc 1. molecular ~nilss 
standard: lane 2. HRSF-TIMP-I (10% SDS-PAGE. silver skncd): 
lane 3, HRSF-TIMP-2 (10% SDS-PAGE, siivcr stained); lane 4, 
HRSF-TlMP-I. in~n~unologicully dctccted by TIMP-I antibody; lane 
5. HRSF-TIMP-2. no cross reaction with TIMP-I antibody. 
vared by reduction and carboxamidomethylation, A 
specific antibody raised against the isolated TIMP-I 
only detected this inhibitor but not TIMP-2 (Fig. 3). 
Rheumatoid synovial fluid TIMP-1 and TIMP-2 are 
both able to inhibit active leucocyte gelatinasc and col- 
Iagenase. Autocatalytic degradation of these enzymes 
did not take place in the presence of either of these 
inhibitors. 
Comp!e:r formation between the active leucocyte ma- 
Table 1 
SlImmary ot pwllkntion of TIMP-I end TIMP-2 from humn rlwumetoid synovlal fluid 
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Fig. 4. Detection or human leucocytc metallopro~einase~:rrlMP com- 
plexes by immunoblotting. Lane 1. HRSF-TIMP-I: lane 2. HRSF- 
TIMP-I, A. bloated inllibirors incubavd for 2 h with ltitent leucocylc 
collagonnse and analyzed with col&cnase antibody: B, bloltrd inhibi- 
tors incubated Ibr 7 II with latent lcucocyte gelatintisc and analyzed 
wilh gclatinase IgG; C. as A, bul incubatioti with activated leucocytc 
collapenssc; D. BS B. tx~ incubation with activakd lcucocytc gcluli- 
IlMC. 
trix mctalloproteinases and these inhibitors was also 
demonstrated by immunoblotting (Fig. 4). Blotted inhi- 
bitors were incubated with activated gelatinase or colla- 
genasc. Only a single stained band was detected for each 
inhibitor by the specific antibodies, which recognized 
the complex with the enzyme. Similar results were ob- 
tained for TIMP-I using PMNL progelatinase, while 
such a complex was not detected for TIMP-2. This is in 
agreement with the results of Goldberg [ 1 S]. who found 
that M,. 92 000 progelatinase isolated from SV 40 trans- 
formated fibroblasts is able to form a complex with 
TIMP-1. In contrast PMNL procollagenasc remained 
unbound to TlMP-I or TIMP-2 and no complex forma- 
tion was observed. In summary TIMP-1 and TIMP-2 
are able to form stable complexes with activated PMNL 
collagennse and gelatinasc, but only TIMP-I can form 
a complex with PMNL progelatinase. This demonstra- 
tes that there must be a specilic binding site for TlMP-I 
in latent M, 92 000 gelatinase. Howard et al. have 
shown that M, 72 000 progelatinase forms complexes 
with TIMP2 and perhaps TIMP-2 is 3 stabilizer of this 
enzyme [9]. It would seem that TIMP-1 has the same 
function for Mr 92 000 progelatinase and that the ma- 
trix metalloproteinase inhibitors have more assign- 
ments than just blocking the activated enzymes. 
Furthermore, it was shown that TIMP-I and TIMP-2 
suppressed collagen degradation by activated leucocyte 
collagenase (results not shown). This underlines that 
these inhibitors play an important role in the control of 
matrix metalloproteinases in tissue remodelling. These 
enzymes are able to degrade many extracellular matrix 
components. Therefore. decreased inhibitor levels could 
Tabk 2 
The fux I5 N-rmdn8l amino rcids of hum tiumuoip 6ynoviaJ fluid inhibit (IIMP- 
and TIMP-2) and mparirim with scqucnocr uf inhibiton Fran aihcr -a. 
1 5 10 15 
HRSF-TIMP- 1 *_~~~~~_~~~~~~~_Q._~-A-F-X-N-‘- 
H-TIMP- I C-T-C-V-P-P-H-P-Q-T-A-F-C-N-S- 
HRSF.TlMP.2 X-S-X-S-P-V-H-P-Q-Q-A-F’X-N-A- 
H-TIMP.2 C-S-C-S-P-V-H-P-Q-Q-A-F-C-N-A- 
P I-tRSF-TIMP- 1. human rhcumaloid synuvial fluid TIMP- I 
I%TIMP-I, human IIMP- repned by Docbcfly cl nl. 1 IS1 
HRSF-‘IIMP-2. human rheumatoid synovial fluid TIMP-2 
It-TIMP-2, humnn TIMP.2 rcpncd by S~c~cr-~~erc~~wt~ ci d. i?i d hz c': d. 
1171 
x = unidcmiricd vmlno acid 
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lead to unbalanced matrix degradation as observed in 
pathological conditions such as rheumatoid arthritis. 
This is the first report that TIMP-I as well as TIMP-2 
are present in human rheumatoid synovial fluid and 
that both inhibitors can be isolated from this body fluid 
by a simple chromatographic procedure. Future investi- 
gations need to clarify the roles of TIMP-1 and TIMP-2 
in diseases uch as rheumatoid arthritis. This could per- 
haps help to develop therapeutic approaches to inhibit 
matrix degradation. 
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